41 – 50 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Hormone-sensitive lipase (HSL) is also a retinyl ester hydrolase: evidence from mice lacking HSL.
2009) In The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 23(7). p.2307-2316(
- Contribution to journal › Article
-
Mark
Compound tissue imaging signal output generated by different matrix deposition platforms
(
- Contribution to journal › Published meeting abstract
-
Mark
The Signal Intensity in Imaging MALDI-MS Is Dependent on Matrix Deposition
(
- Contribution to journal › Published meeting abstract
-
Mark
Twins studies as a model for studies on the interaction between smoking and genetic factors in the development of chronic bronchitis
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Variants in MTNR1B influence fasting glucose levels
(
- Contribution to journal › Article
- 2008
-
Mark
Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations
(
- Contribution to journal › Article
-
Mark
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
(
- Contribution to journal › Article
- 2007
-
Mark
DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
(
- Contribution to journal › Article
-
Mark
Protein Expression Patterns Associated with Progression of Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage of Smokers.
(
- Contribution to journal › Article
-
Mark
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial
(
- Contribution to journal › Article